← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 1, 2018Last known activity
Dec 25, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 3 trials)
Phase 2 (1 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT04926428Lead sponsorN/ADec 25, 2020
- NCT04405310Reponsible party - principal investigatorPhase 2May 20, 2020
- NCT04405310Lead sponsorPhase 2May 20, 2020
- NCT03784794Lead sponsorN/ANov 1, 2018
- NCT03784794Sponsor investigatorN/ANov 1, 2018
- NCT03784794CollaboratorN/ANov 1, 2018
- NCT03784794Overall official - principal investigatorN/ANov 1, 2018
Details
- Last known activity
- Dec 25, 2020